Rockefeller Capital Management
CDNA icon

Rockefeller Capital Management’s CareDx CDNA Stock Holding History

Rockefeller Capital Management’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$182K Sell
6,377
-469
-7% -$10.2K ﹤0.01% 2651
2026
Q1 		$119K Buy
6,846
+711
+12% +$13.5K ﹤0.01% 2776
2025
Q4 		$116K Buy
6,135
+178
+3% +$2.98K ﹤0.01% 2650
2025
Q3 		$86.6K Buy
+5,957
New +$84.9K ﹤0.01% 2638
2023
Q1 		– Sell
-3,985
Closed -$45K – 2274
2022
Q4 		$45K Sell
3,985
-123
-3% -$1.82K ﹤0.01% 2437
2022
Q3 		$69K Buy
4,108
+3,005
+272% +$64.5K ﹤0.01% 2190
2022
Q2 		$23K Buy
1,103
+192
+21% +$5.33K ﹤0.01% 2656
2022
Q1 		$33K Sell
911
-1
-0.1% -$39 ﹤0.01% 2495
2021
Q4 		$41K Buy
912
+11
+1% +$574 ﹤0.01% 2301
2021
Q3 		$57K Sell
901
-866
-49% -$65.9K ﹤0.01% 2077
2021
Q2 		$161K Buy
1,767
+15
+0.9% +$1.19K ﹤0.01% 1596
2021
Q1 		$119K Buy
1,752
+643
+58% +$49.9K ﹤0.01% 1528
2020
Q4 		$80K Buy
1,109
+41
+4% +$2.38K ﹤0.01% 1528
2020
Q3 		$40K Buy
1,068
+39
+4% +$1.32K ﹤0.01% 1569
2020
Q2 		$36K Buy
+1,029
New +$29.3K ﹤0.01% 1494

Other funds holding CDNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Rockefeller Capital Management's CDNA Position: Q2 2026 in Review

Rockefeller Capital Management reduced its CareDx (CDNA) stake by 6.9% in Q2 2026, selling an estimated $10.2K and leaving 6,377 shares worth $182K. The position accounts for ﹤0.01% of the portfolio, ranked #2651.

Rockefeller Capital Management first reported a position in CDNA in Q2 2020 and has held it in 15 quarters since. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Rockefeller Capital Management held 6,377 shares of CareDx worth $182K as of Q2 2026.
  • Rockefeller Capital Management sold 469 CareDx shares in Q2 2026, an estimated $10.2K.
  • CareDx made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #2651 holding.
  • Rockefeller Capital Management first reported a position in CareDx in Q2 2020 and has held it in 15 quarters since.
  • 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.